EUVIMEDEUVIMED entdecken
Kohortenstudie

Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study

Kyoung Jin Kim iD, Seong Hee Ahn, So Young Park iD, Jimi Choi iD, Gi Hwan Bae, Ha-Young Kim, Kyoung Min Kim iD, KSBMR Epidemiology Study Group

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae111 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Kyoung Jin Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Osteoporosis, Postmenopausal, Bone Density Conservation Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Osteoporosis-related fractures are associated with increased mortality risk among postmenopausal women, yet the impact of antiosteoporotic medications on mortality is not fully understood.

Objective

This study evaluates the effect of antiresorptive agents (ARs) on mortality risk in postmenopausal women with osteoporosis.

Design

This is a nationwide cohort study using data from the National Screening Program for Transitional Ages (2008-2017).

Setting

Data were derived from a national cohort of postmenopausal women in South Korea.

Participants

This study included 117 871 postmenopausal women diagnosed with osteoporosis. Of them, 15 895 patients who used ARs, such as bisphosphonates or selective estrogen receptor modulators, for at least 1 year were matched 1:1 with nonusers using propensity scores. Exposures Exposure to ARs for at least 1 year was compared with no AR use. Main Outcomes and Measure Mortality outcomes were assessed using multivariable Cox proportional hazard regression models, focusing on all-cause mortality and cause-specific mortality, particularly cardiovascular disease (CVD) and injury-/fracture-related deaths.

Results

In AR users, there were 102 deaths (mortality rate 1.41 per 1000 person-years), compared with 221 deaths in non-users (mortality rate 3.14 per 1000 person-years), yielding a hazard ratio (HR) of 0.43 (95% CI, 0.34-0.54). Antiresorptive agent users showed a 52% reduction in CVD mortality risk (HR, 0.48; 95% CI, 0.34-0.69) and a 54% reduction in injury-/fracture-related mortality risk (HR, 0.46; 95% CI, 0.27-0.76). The analysis indicated a consistent decrease in all-cause and CVD mortality risks with longer durations of AR use. Conclusions and Relevance The use of ARs in postmenopausal women with osteoporosis is associated with significantly lower risks of all-cause mortality, especially from cardiovascular events and fractures. The mortality reduction benefits appear to be enhanced with prolonged AR therapy, highlighting the potential importance of sustained treatment in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoporosis, PostmenopausalBone Density Conservation AgentsHumansFemaleAgedRepublic of KoreaMiddle AgedCohort StudiesPostmenopauseOsteoporotic FracturesDiphosphonatesCardiovascular DiseasesProportional Hazards ModelsMortalityRisk Factors

Stichwörter der Autor:innen

bisphosphonatesepidemiologymortalityosteoporosis

Substanzen

Bone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Koreal.
  • Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
  • Department of Endocrinology, Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.

ORCID-Profile: Kyoung Jin Kim, So Young Park, Jimi Choi, Kyoung Min Kim

Zitieren

APA

Kim, K. J., Ahn, S. H., Park, S. Y., Choi, J., Bae, G. H., Kim, H. Y., Kim, K. M., & KSBMR Epidemiology Study Group (2024). Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae111

Vancouver

Kim KJ, Ahn SH, Park SY, Choi J, Bae GH, Kim HY, et al. Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae111

BibTeX
@article{Kim2024,
  author = {Kim, Kyoung Jin and Ahn, Seong Hee and Park, So Young and Choi, Jimi and Bae, Gi Hwan and Kim, Ha-Young and Kim, Kyoung Min and KSBMR Epidemiology Study Group, KSBMR Epidemiology Study Group},
  title = {Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae111}
}
Kostenlos starten →